cancer clinical trials in alexandria, LA

Phase III Lucanix™ Vaccine Therapy in Advanced Non-small Cell Lung Cancer (NSCLC) Following Front-line Chemotherapy

Hematology Oncology Life Center
Alexandria, Louisiana 71301

Lung Neoplasm, Carcinoma Non-small Cell Lung Cancer Stage IIIA, Carcinoma Non-small Cell Lung Cancer Stage IIIB, Carcinoma Non-small Cell Lung Cancer Stage IV

Selenium in Preventing Tumor Growth in Patients With Previously Resected Stage I Non-small Cell Lung Cancer

Tulane Cancer Center Office of Clinical Research
Alexandria, Louisiana 71315-3198

Lung Cancer

S0221 Adjuvant Doxorubicin, Cyclophosphamide, and Paclitaxel in Treating Patients With Breast Cancer

Tulane Cancer Center Office of Clinical Research
Alexandria, Louisiana 71315-3198

Breast Cancer

Dexamethasone Compared With Prednisone During Induction Therapy and Methotrexate With or Without Leucovorin During Maintenance Therapy in Treating Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia

Tulane Cancer Center Office of Clinical Research
Alexandria, Louisiana 71315-3198

Leukemia

S0106 Cytarabine and Daunorubicin w/ or w/o Gemtuzumab Followed By HD Cytarabine and Either Gemtuzumab or Nothing in de Novo AML

Tulane Cancer Center Office of Clinical Research
Alexandria, Louisiana 71315-3198

Leukemia

Comparison of Radiation Therapy Regimens in Combination With Chemotherapy in Treating Young Patients With Newly Diagnosed Standard-Risk Medulloblastoma

Tulane Cancer Center Office of Clinical Research
Alexandria, Louisiana 71315-3198

Brain Tumor, Central Nervous System Tumor

PANVAC™-VF Vaccine for the Treatment of Metastatic Pancreatic Cancer After Failing a Gemcitabine-Containing Regimen

Hematology Oncology Life Center
Alexandria, Louisiana 71301

Pancreatic Cancer

Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Lymphoblastic Leukemia

Tulane Cancer Center Office of Clinical Research
Alexandria, Louisiana 71315-3198

Leukemia

S-1 as Second-Line Therapy in Treating Patients With Unresectable or Recurrent Stage III or Stage IV Non-Small Cell Lung Cancer

Hematology Oncology Life Center
Alexandria, Louisiana 71301

Lung Cancer

S-1 and Cisplatin as First-Line Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer That Cannot Be Removed By Surgery

Hematology Oncology Life Center
Alexandria, Louisiana 71301

Lung Cancer

S0410 Tandem Stem Cell Transplantation in Treating Patients With Progressive or Recurrent Hodgkin's Lymphoma

Tulane Cancer Center Office of Clinical Research
Alexandria, Louisiana 71315-3198

Lymphoma

Radiation Therapy in Treating Young Patients With Gliomas

Tulane Cancer Center Office of Clinical Research
Alexandria, Louisiana 71315-3198

Brain Tumor, Central Nervous System Tumor

Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer

Tulane Cancer Center Office of Clinical Research
Alexandria, Louisiana 71315-3198

Colorectal Cancer

Radiation Therapy and Cisplatin With or Without Cetuximab in Treating Patients With Stage III or Stage IV Head and Neck Cancer

Tulane Cancer Center Office of Clinical Research
Alexandria, Louisiana 71315-3198

Head and Neck Cancer

Study to Assess Compliance With Long-Term Mercaptopurine Treatment in Young Patients With Acute Lymphoblastic Leukemia in Remission

Tulane Cancer Center Office of Clinical Research
Alexandria, Louisiana 71315-3198

Leukemia

Hormone Therapy and Radiation Therapy or Hormone Therapy and Radiation Therapy Followed by Docetaxel and Prednisone in Treating Patients With Localized Prostate Cancer

Tulane Cancer Center Office of Clinical Research
Alexandria, Louisiana 71315-3198

Prostate Cancer

Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial)

Christus Saint Frances Cabrini Hospital
Alexandria, Louisiana 71301

Estrogen Receptor-positive Breast Cancer, HER2-negative Breast Cancer, Progesterone Receptor-positive Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIB Breast Cancer

Efficacy and Safety of Zoledronic Acid ( Every 4 Weeks vs. Every 12 Weeks) in Patients With Documented Bone Metastases From Bone Cancer

Cabrini Center for Cancer Care
Alexandria, Louisiana 71301

Breast Cancer

Combination Chemotherapy, Radiation Therapy, and/or Surgery in Treating Patients With High-Risk Kidney Tumors

Tulane Cancer Center Office of Clinical Research
Alexandria, Louisiana 71315-3198

Kidney Cancer

S0530 Cytarabine and Clofarabine in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia

Tulane Cancer Center Office of Clinical Research
Alexandria, Louisiana 71315-3198

Leukemia

Zoledronate, Vitamin D, and Calcium With or Without Strontium 89 or Samarium 153 in Preventing or Delaying Bone Problems in Patients With Bone Metastases From Prostate Cancer, Lung Cancer, or Breast Cancer

Tulane Cancer Center Office of Clinical Research
Alexandria, Louisiana 71315-3198

Breast Cancer, Lung Cancer, Metastatic Cancer, Pain, Prostate Cancer

Combination Chemotherapy in Treating Young Patients With Down Syndrome and Acute Myeloid Leukemia or Myelodysplastic Syndromes

Tulane Cancer Center Office of Clinical Research
Alexandria, Louisiana 71315-3198

Leukemia, Myelodysplastic Syndromes

Combination Chemotherapy With or Without Gemtuzumab in Treating Young Patients With Newly Diagnosed Acute Myeloid Leukemia

Tulane Cancer Center Office of Clinical Research
Alexandria, Louisiana 71315-3198

Leukemia

Assessing Ear Damage in Young Cancer Patients Treated With Cisplatin

Tulane Cancer Center Office of Clinical Research
Alexandria, Louisiana 71315-3198

Ototoxicity, Unspecified Childhood Solid Tumor, Protocol Specific

Combination Chemotherapy in Treating Young Patients With Recurrent or Resistant Malignant Germ Cell Tumors

Tulane Cancer Center Office of Clinical Research
Alexandria, Louisiana 71315-3198

Childhood Germ Cell Tumor, Extragonadal Germ Cell Tumor, Ovarian Cancer, Testicular Germ Cell Tumor

S0521, Combination Chemotherapy With or Without Gemtuzumab Followed By Tretinoin, Mercaptopurine, and Methotrexate or Observation in Treating Patients With Acute Promyelocytic Leukemia

Tulane Cancer Center Office of Clinical Research
Alexandria, Louisiana 71315-3198

Leukemia

Combination Chemotherapy and Surgery With or Without Isotretinoin in Treating Young Patients With Neuroblastoma

Tulane Cancer Center Office of Clinical Research
Alexandria, Louisiana 71315-3198

Neuroblastoma

Randomized Phase 3b Study in Previously Untreated Multiple Myeloma Patients: VELCADE,Thalidomide, and Dexamethasone Versus VELCADE and Dexamethasone Versus VELCADE, Melphalan, and Prednisone

Christus St. Francis Cabrini Cancer Center
Alexandria, Louisiana 71301

Multiple Myeloma

Radiation Therapy, Androgen Suppression, and Docetaxel in Treating Patients With High-Risk Prostate Cancer Who Have Undergone Radical Prostatectomy

Tulane Cancer Center Office of Clinical Research
Alexandria, Louisiana 71315-3198

Prostate Cancer

High-Dose or Standard-Dose Radiation Therapy and Chemotherapy With or Without Cetuximab in Treating Patients With Newly Diagnosed Stage III Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery

Tulane Cancer Center Office of Clinical Research
Alexandria, Louisiana 71315-3198

Lung Cancer, Radiation Toxicity

Samarium Sm 153 Lexidronam Pentasodium and 3-Dimensional Conformal Radiation Therapy or Intensity-Modulated Radiation Therapy in Treating Patients With Rising Prostate-Specific Antigen Levels After Radical Prostatectomy for Prostate Cancer

Tulane Cancer Center Office of Clinical Research
Alexandria, Louisiana 71315-3198

Prostate Cancer

Combination Chemotherapy With or Without Lestaurtinib in Treating Infants With Newly Diagnosed Acute Lymphoblastic Leukemia

Tulane Cancer Center Office of Clinical Research
Alexandria, Louisiana 71315-3198

Leukemia

Comparing Two Different Myeloablation Therapies in Treating Young Patients Who Are Undergoing a Stem Cell Transplant for High-Risk Neuroblastoma

Tulane Cancer Center Office of Clinical Research
Alexandria, Louisiana 71315-3198

Neuroblastoma

Prostate Radiation Therapy or Short-Term Androgen Deprivation Therapy and Pelvic Lymph Node Radiation Therapy With or Without Prostate Radiation Therapy in Treating Patients With a Rising Prostate Specific Antigen (PSA) After Surgery for Prostate Cancer

Tulane Cancer Center Office of Clinical Research
Alexandria, Louisiana 71315-3198

Prostate Cancer

Gemcitabine Hydrochloride and Erlotinib Hydrochloride With or Without Monoclonal Antibody Therapy in Treating Patients With Metastatic Pancreatic Cancer That Cannot Be Removed By Surgery

Christus Saint Frances Cabrini Hospital
Alexandria, Louisiana 71301

Stage IV Pancreatic Cancer

Carboplatin, Docetaxel, Bevacizumab, and Erlotinib Versus Chemotherapy Alone in Resected NSCLC

Hematology Oncology Life Center
Alexandria, Louisiana 71301

Non-Small Cell Lung Cancer

Three Different Radiation Therapy Regimens in Treating Patients With Limited-Stage Small Cell Lung Cancer Receiving Cisplatin and Etoposide

Tulane Cancer Center Office of Clinical Research
Alexandria, Louisiana 71315-3198

Lung Cancer

Daunorubicin, Cytarabine, and Midostaurin in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia

Tulane Cancer Center Office of Clinical Research
Alexandria, Louisiana 71315-3198

Leukemia

Sodium Thiosulfate in Preventing Hearing Loss in Young Patients Receiving Cisplatin for Newly Diagnosed Germ Cell Tumor, Hepatoblastoma, Medulloblastoma, Neuroblastoma, Osteosarcoma, or Other Malignancy

Tulane Cancer Center Office of Clinical Research
Alexandria, Louisiana 71315-3198

Brain and Central Nervous System Tumors, Childhood Germ Cell Tumor, Extragonadal Germ Cell Tumor, Liver Cancer, Neuroblastoma, Ototoxicity, Ovarian Cancer, Sarcoma

Stereotactic Body Radiation Therapy in Treating Patients With Stage I Non-Small Cell Lung Cancer

Tulane Cancer Center Office of Clinical Research
Alexandria, Louisiana 71315-3198

Lung Cancer

S0715: Acetyl-L-Carnitine in Preventing Neuropathy in Women With Stage I, Stage II, or Stage IIIA Breast Cancer Undergoing Chemotherapy

Tulane Cancer Center Office of Clinical Research

Trial Locations
Tulane Cancer Center Office of Clinical Research
Northeast Louisiana Cancer Institute at St. Francis Medical Center

Breast Cancer, Chemotherapeutic Agent Toxicity, Fatigue, Neuropathy, Neurotoxicity

S0904: Docetaxel With or Without Vandetanib in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer

Tulane Cancer Center Office of Clinical Research
Alexandria, Louisiana 71315-3198

Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer

Bortezomib and Combination Chemotherapy in Treating Young Patients With Relapsed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma

Tulane Cancer Center Office of Clinical Research
Alexandria, Louisiana 71315-3198

Leukemia, Lymphoma

A Clinical Trial Comparing the Combination of TC Plus Bevacizumab to TC Alone and to TAC for Women With Node-Positive or High-Risk Node-Negative, HER2-Negative Breast Cancer

Christus St. Frances Cabrini Hospital
Alexandria, Louisiana 71301

Breast Cancer

Collecting and Storing Samples of Bone Marrow and Blood From Patients With Relapsed Acute Lymphoblastic Leukemia or Non-Hodgkin Lymphoma

Tulane Cancer Center Office of Clinical Research
Alexandria, Louisiana 71315-3198

Leukemia, Lymphoma

Collecting and Storing Malignant, Borderline Malignant Neoplasms, and Related Samples From Young Patients With Cancer

Tulane Cancer Center Office of Clinical Research
Alexandria, Louisiana 71315-3198

Leukemia, Neoplasm of Uncertain Malignant Potential, Unspecified Childhood Solid Tumor, Protocol Specific

Study of Kidney Tumors in Young Patients

Tulane Cancer Center Office of Clinical Research
Alexandria, Louisiana 71315-3198

Kidney Cancer, Nonneoplastic Condition

Collecting and Storing Tissue From Young Patients With Cancer

Tulane Cancer Center Office of Clinical Research
Alexandria, Louisiana 71315-3198

Cancer

Collecting and Storing Samples of Blood and Tumor Tissue From Patients With Osteosarcoma

Tulane Cancer Center Office of Clinical Research
Alexandria, Louisiana 71315-3198

Sarcoma

Collecting and Storing Biological Samples From Patients With Ewing Sarcoma

Tulane Cancer Center Office of Clinical Research
Alexandria, Louisiana 71315-3198

Sarcoma

Collecting and Storing Biological Samples From Young Patients With Hodgkin's Lymphoma

Tulane Cancer Center Office of Clinical Research
Alexandria, Louisiana 71315-3198

Lymphoma

S0120, Studying Blood and Bone Marrow Samples From Patients With Monoclonal Gammopathy of Undetermined Significance, Multiple Myeloma, or Plasmacytoma

Tulane Cancer Center Office of Clinical Research
Alexandria, Louisiana 71315-3198

Multiple Myeloma, Plasma Cell Myeloma, Precancerous Condition

Biomarkers in Tumor Tissue Samples From Patients With Newly Diagnosed Neuroblastoma or Ganglioneuroblastoma

Tulane Cancer Center Office of Clinical Research
Alexandria, Louisiana 71315-3198

Neuroblastoma

Collecting and Storing Blood and Brain Tumor Tissue Samples From Children With Brain Tumors

Tulane Cancer Center Office of Clinical Research
Alexandria, Louisiana 71315-3198

Brain and Central Nervous System Tumors

Radiation Therapy With or Without Androgen-Deprivation Therapy in Treating Patients With Prostate Cancer

Tulane Cancer Center Office of Clinical Research
Alexandria, Louisiana 71315-3198

Prostate Cancer

Carboplatin and Paclitaxel With or Without Cisplatin and Radiation Therapy in Treating Patients With Stage I, Stage II, Stage III, or Stage IVA Endometrial Cancer

Tulane Cancer Center Office of Clinical Research
Alexandria, Louisiana 71315-3198

Endometrial Cancer

S0910 Epratuzumab, Cytarabine, and Clofarabine in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia

Tulane Cancer Center Office of Clinical Research
Alexandria, Louisiana 71315-3198

Leukemia

S0819: Carboplatin/Paclitaxel With or Without Bevacizumab and/or Cetuximab in Stage IV or Recurrent Non-Small Cell Lung Cancer

Tulane Cancer Center Office of Clinical Research
Alexandria, Louisiana 71315-3198

Lung Cancer

Radiation Therapy With or Without Cetuximab in Treating Patients Who Have Undergone Surgery for Locally Advanced Head and Neck Cancer

Tulane Cancer Center Office of Clinical Research
Alexandria, Louisiana 71315-3198

Head and Neck Cancer

Study of Blood Samples From Newborns With Down Syndrome

Tulane Cancer Center Office of Clinical Research
Alexandria, Louisiana 71315-3198

Leukemia

Vorinostat, Rituximab, and Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Diffuse Large B-Cell Lymphoma

Christus Saint Frances Cabrini Hospital
Alexandria, Louisiana 71301

Contiguous Stage II Adult Diffuse Large Cell Lymphoma, Noncontiguous Stage II Adult Diffuse Large Cell Lymphoma, Stage III Adult Diffuse Large Cell Lymphoma, Stage IV Adult Diffuse Large Cell Lymphoma

Rosuvastatin in Treating Patients With Stage I or Stage II Colon Cancer That Was Removed By Surgery

Tulane Cancer Center Office of Clinical Research

Trial Locations
Tulane Cancer Center Office of Clinical Research
CHRISTUS Cabrini Cancer Center

Colorectal Cancer, Precancerous Condition

Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With Surgery

CHRISTUS Cabrini Cancer Center
Alexandria, Louisiana 71301

Colorectal Cancer

A Safety and Efficacy Study of Farletuzumab in Subjects With Adenocarcinoma of the Lung

Christus Saint Frances, Cabrini Hospital, Cabrini Cancer Center
Alexandria, Louisiana 71301

Adenocarcinoma of the Lung

CMR Rate of Newly Diagnosed CML-CP Patients Treated With Nilotinib

Cabrini Center for Cancer Care
Alexandria, Louisiana 71301

Chronic Myelogenous Leukemia in Chronic Phase

Early Surgery or Standard Palliative Therapy in Treating Patients With Stage IV Breast Cancer

Tulane Cancer Center Office of Clinical Research
Alexandria, Louisiana 71315-3198

Breast Cancer

Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer

Christus Saint Frances Cabrini Hospital
Alexandria, Louisiana 71301

Estrogen Receptor-negative Breast Cancer, Estrogen Receptor-positive Breast Cancer, HER2-positive Breast Cancer, Progesterone Receptor-negative Breast Cancer, Progesterone Receptor-positive Breast Cancer, Recurrent Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer, Stage IIIC Breast Cancer

Caspofungin Acetate or Fluconazole in Preventing Invasive Fungal Infections in Patients With Acute Myeloid Leukemia Who Are Undergoing Chemotherapy

Tulane Cancer Center Office of Clinical Research
Alexandria, Louisiana 71315-3198

Fungal Infection, Leukemia, Neutropenia

S1014 Abiraterone Acetate in Treating Patients With Prostate Cancer Who Have Undergone Initial Hormone Therapy

Tulane Cancer Center Office of Clinical Research
Alexandria, Louisiana 71315-3198

Prostate Cancer

Join the directory

Join the Community

Join the Directory